PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study

Area of Science:

• Neuroscience
• Ophthalmology
• Retinal Degeneration Research

Background:

• Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors are present in the retina.
• PACAP has known retinoprotective effects demonstrated in various retinal degeneration models.
• Previous studies showed PACAP protects against monosodium glutamate (MSG)-induced morphological damage in rat retinas.

Purpose of the Study:

• To investigate the functional consequences of MSG-induced retinal damage.
• To evaluate the functional recovery of the retina after PACAP administration in MSG-treated rats.
• To assess the impact of PACAP on electroretinographic measurements in a model of retinal excitotoxicity.

Main Methods:

• Intravitreal PACAP administration in neonatal rats subjected to MSG-induced retinal damage.
• Histological and morphometrical analyses to assess retinal structure.
• Electroretinography (ERG) to measure retinal function (a-wave and b-wave).

Main Results:

• Histological data confirmed PACAP's protective effect against MSG-induced retinal damage.
• ERG recordings showed a significant decrease in a-wave and b-wave values in MSG-treated retinas.
• PACAP treatment significantly increased a-wave and b-wave values, indicating functional improvement.

Conclusions:

• PACAP treatment significantly improves the functional properties of the retina in cases of excitotoxic damage.
• While not perfectly parallel to morphological recovery, functional outcomes are notably enhanced by PACAP.
• These findings highlight the clinical potential of PACAP for treating retinal excitotoxicity.